Hadjiconstantinou, M <br/><br/>
Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse.  [electronic resource] 

 -  Journal of neurochemistry  Aug 1991 
 - 479-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-3042 
<br/><br/><label>Standard No.: </label>10.1111/j.1471-4159.1991.tb03776.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine--pharmacology<br/>3,4-Dihydroxyphenylacetic Acid--metabolism<br/>Animals<br/>Cells, Cultured<br/>Cerebral Ventricles--drug effects<br/>Corpus Striatum--drug effects<br/>Dopamine--metabolism<br/>Embryo, Mammalian<br/>Epidermal Growth Factor--administration & dosage<br/>Infusions, Parenteral<br/>Male<br/>Mesencephalon--drug effects<br/>Mice<br/>Reference Values<br/>Tyrosine 3-Monooxygenase--metabolism